Recent Updates
Recently added Catalysts
KURA Positive Sentiment

Kura Oncology to Participate in Stifel Targeted Oncology Forum

Tuesday, April 1, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Kura Oncology, Inc. announced its participation in the upcoming Stifel 2025 Virtual Targeted Oncology Forum. CEO Troy Wilson will host a virtual fireside chat on April 8, 2025. An audio webcast of the event will be available, allowing investors and interested parties to access insights directly from the company. This participation highlights Kura's focus on precision medicines in cancer treatment.
Price reaction · baseline $6.6 (2025-03-31 close) · hit after-hours · 1 other KURA headline(s) in the window, move may be shared
day 0 close · peak
-3.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent industry forum enhances visibility.
  • Engagement from the CEO indicates strong leadership commitment.
  • Opportunity to share advancements in precision medicine.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+116%
120-day peak, hindsight
Typical move
5.7%
average across 9 past catalysts
Cash runway
~25 mo
Low dilution risk
Lead asset
Tipifarnib
Phase 2 · Leukemia, Myelomonocytic, Chronic

Full Press Release Details

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the Stifel 2025 Virtual Targeted Oncology Forum. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at 10:30 a.m. ET / 7:30 a.m. PT on April 8, 2025. A live audio webcast of the fireside chat will be available in the Investors section of Kura’s website at www.kuraoncology.com, with an archived replay following the event.
patti.bank@icrhealthcare.com
Alexandra Weingarten

Frequently Asked Questions

When is Kura Oncology's fireside chat scheduled?

The fireside chat is scheduled for April 8, 2025, at 10:30 a.m. ET.

Where can I watch the Kura Oncology webcast?

The webcast will be available in the Investors section of Kura’s website.

Who is speaking at the oncology forum?

Troy Wilson, Ph.D., J.D., will represent Kura Oncology at the forum.

Will there be a replay of the chat available?

Yes, an archived replay of the fireside chat will be available after the event.

What is Kura Oncology focused on?

Kura Oncology specializes in precision medicines for cancer treatment.

ShareAdd on Google
Tags: KURA Viatris Investor Conferences Healthcare Kura Oncology Stifel Forum precision medicine cancer treatment Troy Wilson
Last updated: Apr 1, 2025

Biotech snapshot

Cash runway
$519M liquidity · $21M/mo burn
~25 mo
Low dilution risk
Lead asset
TipifarnibPhase 2
Leukemia, Myelomonocytic, Chronic →

Catalyst track record

+116%
best trade around KURA's most recent catalyst

Peak hindsight return over a 120-day window, across 9 tracked FDA/PDUFA catalysts for KURA.

See every catalyst's timing & PoA →